Analyst Research Report Snapshot

Title:

IMMUNODIAGNOSTIC SYSTEM HOLDINGS - ANOTHER FRESH START?

Price:

$10.00

Provider:

Edison Investment Research

Date:

27 Nov 2012

Pages:

2

Type:

AcrobatPDF

Companies referenced:

IDH.L

Available for Immediate Download
Summary:

The interims highlight the magnitude of the issues facing IDS. New management will focus on creating new specialist assays that can “anchor” IDS as a vital provider (as Vit D has done previously). Efforts will also target geographic expansion, although it is admittedly late in entering high-growth countries such as China, India and Brazil. The next-generation IDS-iSYS system is also being developed, with a greater integration with the “tracked” systems used by the larger labs. The broadening out of the assay range is a key element, although this will likely require an acquisition.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.